The Hematology/Oncology Fellowship program is the latest ACGME-approved program for the University of Tennessee Graduate School of Medicine (GSM). We are currently accepting applications for the start of the 2022-2023 academic year with two open positions. This will be a combined three-year training program preparing fellows for ABIM board eligibility in both hematology and medical oncology. We plan to recruit two new fellows each year for a maximum of six fellows. Please find out more details on how to apply via ERAS.
Our Hematology Oncology program will train internal medicine graduates to become dual-board eligible in hematology and medical oncology. They will receive education and field-training in the following course rotations:
Participation by fellows in teaching residents and medical students is also an integral part of the training.
Fellows will have ample opportunities to enhance their research skills (both basic science and translational science) and multiple avenues to conduct research in their areas of interest. For example, they will participate in cancer-related clinical trials through the Office of Clinical Trials and can explore the newly established Bone Marrow Transplantation and Cellular Therapy Program at UTMCK. This program will serve a huge need in the East TN region and will provide both autologous and allogeneic transplantation as well as innovative therapies such as chimeric antigen receptor cells (CAR-T) therapy. They are also developing relationships with all commercial CAR-T companies to allow patients access to all available FDA-approved CAR-T products. Fellows will also have the chance to work with Dr. Jonathan Wall and the Amyloidosis and Cancer Theranostics Program (ACTP) for their clinical studies. Their work aims to improve the prognosis and quality of life for patients with amyloidosis through the development of additional imaging agents, and most importantly, new treatments designed to clear amyloid aggregates from the body.
The Cancer Institute is one of the medical center's six Centers of Excellence. Each center is dedicated to providing comprehensive care to patients and expert commitment plays a critical role in the hospital's ongoing success. The Cancer Institute brings together expertise in clinical care, teaching and research. Patients receive exceptional healthcare combined with patient-centered care, premier technology and extensive patient/community education in one convenient outpatient facility.
The Cancer Institute provides comprehensive cancer services, from prevention to treatment. Learn more.
Timothy J. Panella, MD is the Director of the Hematology Oncology fellowship program. Dr. Panella received his MD from the University of Tennessee College of Medicine in Memphis, TN. He completed his residency at University of Massachusetts in Worchester, MA as well as his fellowship in hematology oncology at Duke University School of Medicine in Durham, NC. Dr. Panella also completed a master’s degree in medical management at Tulane University in New Orleans, LA.
The University of Tennessee Graduate School of Medicine
1924 Alcoa Highway
Knoxville, Tennessee 37920 | 865-305-9290
Copyright © 2023